AbbVie Reports Second-Quarter 2024 Financial Results | AbbVie

Jul 25, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share …

CouponFollow Extension

$10.61
OFF

AbbVie Reports Second-Quarter 2024 Financial Results | AbbVie

1 week from now

Jul 25, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share …

abbvie.com

3%
OFF

AbbVie Second Quarter 2024 Earnings: Revenues Beat …

1 week from now

Jul 27, 2024 · AbbVie ( NYSE:ABBV ) Second Quarter 2024 Results Key Financial Results Revenue: US$14.5b (up 4.3% from 2Q 2023). Net...

yahoo.com

1%
OFF

AbbVie’s Q2 2024 Net Earnings Drop To $1.37bn - Yahoo Finance

1 week from now

Jul 26, 2024 · AbbVie has announced its financial results for the second quarter (Q2) of 2024, revealing a 32.1% decrease in net earnings attributable to the company of $1.37bn from …

yahoo.com

18%
OFF

AbbVie Q2 2024 Earnings Report: Strong Revenue Growth Despite ...

1 week from now

Jul 25, 2024 · At the last closing, AbbVie’s stock price was $176.21, with a notable annual increase of 24.18%. Conclusion: AbbVie’s Q2 2024 earnings report presents a mixed yet …

theglobeandmail.com

$2.65
OFF

ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue For Q2 2024

1 week from now

Jul 25, 2024 · AbbVie (NYSE: ABBV) just reported results for the second quarter of 2024.. AbbVie reported earnings per share of $2.65. This was above the analyst estimate for EPS of $2.57. …

investorplace.com

$0.88
OFF

AbbVie Reports Third-Quarter 2024 Financial Results | AbbVie

1 week from now

Oct 30, 2024 · Reports Third-Quarter Diluted EPS of $0.88 on a GAAP Basis, a Decrease of 12.0 Percent; Adjusted Diluted EPS of $3.00, an Increase of 1.7 Percent; These Results Include an …

abbvie.com

$10.97
OFF

AbbVie Reports First-Quarter 2024 Financial Results

1 week from now

Apr 26, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.97 - $11.17 to $11.13 - $11.33, which includes an unfavorable impact of $0.08 per share …

abbvie.com

$10.61
OFF

AbbVie Reports Second-Quarter 2024 Financial Results - PR …

1 week from now

Jul 25, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share …

prnewswire.com

$139
OFF

Altimmune Announces Third Quarter 2024 Financial Results And …

1 week from now

Sep 30, 2024 · Financial Results for the Three Months Ended September 30, 2024: Altimmune had cash, cash equivalents and short-term investments totaling $139.4 million on September …

altimmune.com

$0.77
OFF

AbbVie Reports Second-Quarter 2024 Financial Results - GuruFocus

1 week from now

PR NewswireNORTH CHICAGO, Ill., July 25, 2024 Reports Second-Quarter Diluted EPS of $0.77 on a GAAP Basis, a Decrease of 32.5 Percent; Adjusted Diluted EPS

gurufocus.com

102%
OFF

ABVC BioPharma, Inc. Reports Q3 2024 Financial Results And

1 week from now

Sep 30, 2024 · ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year. Incremental Payments Received based on Executed …

nasdaq.com

$10.61
OFF

AbbVie Reports Second-Quarter 2024 Financial Results

1 week from now

Jul 25, 2024 · AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share …

stocktitan.net

FAQs about AbbVie Reports Second-Quarter 2024 Financial Results | AbbVie Coupon?

How did AbbVie perform in Q2 2024?

In February 2024, the company reported a decrease in net revenues to $54.32bn for the year ended 31 December 2023 - a 6.4% decline from the previous year’s $58.05bn. "AbbVie’s Q2 2024 net earnings drop to $1.37bn" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. ...

When will AbbVie announce its second-quarter 2024 financial results?

NORTH CHICAGO, Ill., July 2, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) will announce its second-quarter 2024 financial results on Thursday, July 25, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. ...

Should you buy AbbVie (ABV) in Q2 2024?

Analysts have set an average target price of $190.31 for AbbVie over the next 12 months, rating it as a strong buy. At the last closing, AbbVie’s stock price was $176.21, with a notable annual increase of 24.18%. AbbVie’s Q2 2024 earnings report presents a mixed yet promising outlook. ...

How did AbbVie perform in the second quarter?

AbbVie Inc (ABBV) recently released its financial results for the second quarter ending June 30, 2024. The company’s performance has provided insightful data regarding its operational success and challenges. AbbVie reported second-quarter net revenues of $14.462 billion, marking a 4.3% increase on a reported basis and 5.6% on an operational basis. ...

What is AbbVie's diluted EPS guidance for 2024?

AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.61 - $10.81 to $10.71 - $10.91, which includes an unfavorable impact of $0.60 per share related to acquired IPR&D and milestones expense incurred year-to-date through the second quarter 2024. ...

Will AbbVie participate in bank of America Securities healthcare conference 2024?

NORTH CHICAGO, Ill. , May 6, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024 . Robert A. Michael , president and chief operating officer, Scott T. Reents , executive vice president, chief financial officer, ...